Distribution of phylogenetic groups, sequence type ST131, and virulence-associated traits among Escherichia coli isolates from men with pyelonephritis or cystitis and healthy controls

Clinical Microbiology and Infection

Volumn 19, Issue 4, 2013, Pages

  Kudinha, T ^a,b   Johnson, J R ^c   Andrew, S D ^a   Kong, F ^b   Anderson, P ^a   Gilbert, G L ^b,d  

^a CHARLES STURT UNIVERSITY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Clonal; Escherichia coli; Phylogenetic; Urinary tract infections; Virulence factors

Indexed keywords

O ANTIGEN; VIRULENCE FACTOR;

ADULT; AGED; ARTICLE; AUSTRALIA; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CLONE; CONTROLLED STUDY; CYSTITIS; ESCHERICHIA COLI; FECES ANALYSIS; GENETIC ASSOCIATION; GENETIC TRAIT; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATHOGENESIS; PHYLOGENY; PRIORITY JOURNAL; PYELONEPHRITIS; URINARY TRACT INFECTION;

ESCHERICHIA COLI;

EID: 84875503879     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12123     Document Type: Article

References (30)

1. Patton JP, Nash DB, Abrutyn E. Urinary tract infection: economic considerations. Med Clin North Am 1991; 75: 495-513.
2. Ruiz J, Simon K, Horcajada JP, et al. Differences in virulence factors among Escherichia coli causing cystitis and pyelonephritis in women and prostatitis in men. J Clin Microbiol 2002; 40: 4445-4449.
3. Johnson JR, Clermont O, Menard M, Kuskowski MA, Picard B, Denamur E. Experimental mouse lethality of Escherichia coli isolates, in relation to accessory traits, phylogenetic group, and ecological source. J Infect Dis 2006; 94: 1141-1150.
4. Moreno E, Andreu A, Perez T, Sabate M, Johnson JR, Prats G. Relationship between Escherichia coli strains causing urinary tract infection in women and the dominant faecal flora of the same hosts. Epidemiol Infect 2006; 134: 1015-1023.
5. Lipsky BA. Urinary tract infections in men. Epidemiology, pathophysiology, diagnosis, and treatment.. Ann Intern Med 1989; 110: 138-150.
6. Sannes MR, Kuskowski MA, Owens K, Gajewski A, Johnson JR. Virulence factor profiles and phylogenetic background of Escherichia coli isolates from veterans with bacteremia versus uninfected control patients. J Infect Dis 2004; 190: 2121-2128.
7. Lidin-Janson G, Kaijser B, Lincoln K, Olling S, Wedel H. The homogeneity of the fecal coliform flora of normal school-girls, characterized by serological and biochemical properties. Med Microbiol Immunol 1978; 164: 247-253.
8. Kudinha T, Kong F, Johnson JR, Andrew SD, Anderson P, Gilbert GL. Multiplex PCR-based reverse line blot for simultaneous detection of 22 virulence genes in uropathogenic Escherichia coli. Appl Environ Microbiol 2012; 78: 1198-1202.
9. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66: 4555-4558.
10. Clermont O, Johnson JR, Menard M, Denamur E. Determination of Escherichia coli O types by allele-specific polymerase chain reaction: application to the O types involved in human septicemia. Diagn Microbiol Infect Dis 2007; 57: 129-136.
11. Johnson JR, Menard M, Johnston B, Kuskowski MA, Nichol K, Zhanel GG. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial resistant urinary tract infections in Canada, 2002-2004. Antimicrob Agents Chemother 2009; 53: 2733-2739.
12. Clermont O, Dhanji H, Upton M, et al. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J Antimicrob Chemother 2009; 64: 274-277.
13. Johnson JR, Owens K, Gajewski A, Kuskowski A. Bacterial characteristics in relation to clinical source of Escherichia coli isolates from women with acute cystitis or pyelonephritis and uninfected women. J Clin Microbiol 2005; 43: 6064-6072.
14. Johnson JR, Scheutz F, Ulleryd P, Kuskowski MA, O'Bryan TT, Sandberg T. Host-pathogen relationships among Escherichia coli isolates recovered from men with febrile urinary tract infection. Clin Infect Dis 2005; 40: 813-822.
15. Johnson JR. Microbial virulence determinants and the pathogenesis of urinary tract infection. Infect Dis Clin N Am 2003; 17: 261-278.
16. Johnson JR, Kuskowski MA, Gajewski A, et al. Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis. J Infect Dis 2005; 191: 46-50.
17. Johnson JR, Russo TA. Molecular epidemiology of extraintestinal pathogenic (uropathogenic) Escherichia coli. Int J Med Microbiol 2005; 295: 383-404.
18. Goluszko P, Moseley SL, Truong LD, et al. Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis. J Clin Invest 1997; 99: 1662-1672.
19. Roberts JA, Marklund B.-I, IIver D et al. The Gal(α1-4)Gal specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract. Proc Natl Acad Sci USA 1994; 91: 11889-11893.
20. Boyd EF, Hartl DL. Diversifying selection governs sequence-polymorphisms in the major adhesin proteins fimA, papA, and sfa of Escherichia coli. J Mol Evol 1998; 47: 258-267.
21. Sokurenko EV, Chesnokova V, Dykhuizen DE, et al. Pathogenic adaptation of Escherichia coli by natural variation of the fimH adhesin. Proc Natl Acad Sci USA 1998; 95: 8922-8926.
22. Lim JK, Gunther NWIV, Zhao H, Johnson DE, Keay SK, Mobley HL. In vivo phase variation of Escherichia coli type 1 fimbrial genes in women with urinary tract infection. Infect Immun 1998; 66: 3303-3310.
23. Platell JL, Johnson JR, Cobbold RN, Trott DJ. Multidrug-resistant extraintestinal Escherichia coli of sequence type ST131 in animals and foods. Vet Microbiol 2011; 153: 99-108.
24. Johnson JR, Porter SB, Zhanel G, Kuskowski MA, Denamur E. Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype. Infect Immun 2012; 80: 1554-1562.
25. Lavigne J-P, Vergunst A, Goret L. 2012. Virulence potential and genomic mapping of the worldwide clone Escherichia coli ST131. PLoS ONE 2012; 7: e34294.
26. Dhanji H, Doumith M, Rooney PJ, et al. Real-time PCR detection of the O25b-ST131 clone of Escherichia coli and its CTX-M-15-like extended-spectrum β-lactamases. Int J Antimicrob Agents 2010; 36: 355-358.
27. Duriez P, Clermont O, Bonacorsi S, et al. Commensal Escherichia coli isolates are phylogenetically distributed among geographically distinct human populations. Microbiology 2001; 147: 1671-1676.
28. Frierman JA, Chalmers TC, Smith HJ, Kuebler RR. The importance of β, the type II error, and sample size in the design and interpretation of the randomized control trail: survey of 71 "negative" trials. N Engl J Med 1978; 299: 690-694.
29. Welch RA, Burland V, Plunkett G, et al. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci USA 2002; 99: 17020-17024.
30. Gunther NW, Lockatell IV, Johnson DE, Mobley HLT. In vivo dynamics of type 1 fimbria regulation in uropathogenic Escherichia coli during experimental urinary tract infection. Infect Immun 2001; 69: 2838-2846.